Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Assets: 2010-2021

Historic Assets for Neurocrine Biosciences (NBIX) over the last 11 years, with Sep 2021 value amounting to $2.0 billion.

  • Neurocrine Biosciences' Assets rose 34.25% to $2.0 billion in Q3 2021 from the same period last year, while for Sep 2021 it was $2.0 billion, marking a year-over-year increase of 34.25%. This contributed to the annual value of $1.7 billion for FY2020, which is 32.83% up from last year.
  • Latest data reveals that Neurocrine Biosciences reported Assets of $2.0 billion as of Q3 2021, which was up 3.11% from $2.0 billion recorded in Q2 2021.
  • In the past 5 years, Neurocrine Biosciences' Assets ranged from a high of $2.0 billion in Q3 2021 and a low of $289.4 million during Q1 2017.
  • Over the past 3 years, Neurocrine Biosciences' median Assets value was $1.5 billion (recorded in 2020), while the average stood at $1.5 billion.
  • Per our database at Business Quant, Neurocrine Biosciences' Assets crashed by 37.00% in 2017 and then spiked by 178.67% in 2018.
  • Quarterly analysis of 5 years shows Neurocrine Biosciences' Assets stood at $817.6 million in 2017, then climbed by 21.47% to $993.2 million in 2018, then surged by 31.50% to $1.3 billion in 2019, then soared by 32.83% to $1.7 billion in 2020, then spiked by 34.25% to $2.0 billion in 2021.
  • Its Assets stands at $2.0 billion for Q3 2021, versus $2.0 billion for Q2 2021 and $1.8 billion for Q1 2021.